Senior Counsel, Legal-Business Development & Corporate

Glaxo Smith Kline is looking for a highly experienced Senior Counsel, Legal-Business Development & Corporate, who will help us grow our business and protect our interests. We are looking for a self-motivated, entrepreneurial, and innovative individual to join our team. The successful candidate will be a strategic thinker with a deep understanding of corporate law and the ability to think outside the box.The ideal candidate should possess a JD degree from an accredited law school, with a minimum of 10 years of experience in a law firm or corporate legal environment. They should have experience in structuring and negotiating complex business deals, managing legal risk, and drafting and reviewing legal documents. They should have experience in leading the legal aspects of M&A transactions and be adept at developing, implementing and managing corporate compliance programs.The Senior Counsel will be expected to provide legal advice to business stakeholders and work closely with senior management to identify and evaluate appropriate legal options to achieve business objectives. They must have a strong sense of ethics, integrity and the ability to collaborate effectively with colleagues from across the organization. Excellent communication, problem-solving and organizational skills are essential. The Senior Counsel should be an enthusiastic and proactive team player, with a commitment to working in a fast-paced and dynamic environment.

According to JobzMall, the average salary range for a Senior Counsel, Legal-Business Development & Corporate in Collegeville, PA 19426, USA is $95,000 to $125,000 per year. This range can vary depending on the size of the company, the industry, the qualifications and experience of the candidate, and the geographic location.

GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.